| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/01/2002 | US6458368 As vaccines for immunization |
| 10/01/2002 | US6458367 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein |
| 10/01/2002 | US6458366 Compounds and methods for diagnosis of tuberculosis |
| 10/01/2002 | US6458365 Method for treating headache |
| 10/01/2002 | US6458364 Non-splicing variants of gp350/220 |
| 10/01/2002 | US6458363 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 10/01/2002 | US6458362 Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopes |
| 10/01/2002 | US6458360 Soluble complement regulatory molecules |
| 10/01/2002 | US6458359 Chimeric gene formed by the dna sequences that encode the antigenic determinants of four proteins of l. infantum and protein encoded by said gene, and pharmacuetical composition useful for preventing and/or treating leishmaniosis in animals or humans |
| 10/01/2002 | US6458358 Compounds encoding the protective M-like protein of Streptococcus equi and assays therefor |
| 10/01/2002 | US6458356 Antibody-induced apoptosis |
| 10/01/2002 | US6458354 Molecular complexes which modify immune responses |
| 10/01/2002 | US6458353 Anti-CCR2 antibodies and methods of use therefor |
| 10/01/2002 | CA2224460C Process for producing gm2 specific antibodies |
| 10/01/2002 | CA2220461C Therapeutic compounds comprised of anti-fc receptor antibodies |
| 10/01/2002 | CA2168459C Fusion proteins containing the c-terminal of tetanus toxin linked to a heterologous protein |
| 10/01/2002 | CA2119930C Production of chimeric antibodies - a combinatorial approach |
| 10/01/2002 | CA2109602C Methods for producing members of specific binding pairs |
| 10/01/2002 | CA2077670C Method for enhancing antibody transport through capillary barriers |
| 10/01/2002 | CA2073031C Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection |
| 10/01/2002 | CA2069244C Drug-containing protein-bonded liposome |
| 10/01/2002 | CA1341391C Protective peptides derived from human immunodeficiency virus-1 gp160 |
| 09/28/2002 | CA2340455A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 09/26/2002 | WO2002075507A2 Anti-bacterial vaccine compositions |
| 09/26/2002 | WO2002075304A1 Method of examining allergic disease |
| 09/26/2002 | WO2002075275A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | WO2002074938A1 Methods for producing antibodies in mammals |
| 09/26/2002 | WO2002074922A2 Compositions and methods for modulating an immune response |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074903A2 Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| 09/26/2002 | WO2002074802A2 Recombinant p. vivax merozoite protein-1 p42 vaccine |
| 09/26/2002 | WO2002074798A2 The genome of a bifidobacterium |
| 09/26/2002 | WO2002074795A2 Oligomeric complexes of chimeric proteins with enhanced immunogenic potential |
| 09/26/2002 | WO2002074788A2 TRP2 ISOFORM TRP2-6b CONTAINING HLA-A2-RESTRICTED EPITOPES |
| 09/26/2002 | WO2002074783A2 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | WO2002074345A2 Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
| 09/26/2002 | WO2002074338A1 Semi-allogenic anti-tumour vaccine with hla haplo-identical antigen-presenting cells |
| 09/26/2002 | WO2002074337A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 09/26/2002 | WO2002074336A2 Influenza vaccine formulations for intradermal delivery |
| 09/26/2002 | WO2002074335A2 Equine herpesvirus vaccine |
| 09/26/2002 | WO2002074333A2 Mycobacterial extracts used for treating allergy |
| 09/26/2002 | WO2002074332A2 Method to enhance the immunogenicity of an antigen |
| 09/26/2002 | WO2002074331A2 Mutated mhc molecules for use in immune suppression |
| 09/26/2002 | WO2002074330A2 Mycobacterrial estracts for treating autoimmune diseases |
| 09/26/2002 | WO2002074325A1 Patch for transcutaneous immunization |
| 09/26/2002 | WO2002074324A1 Collagen-binding adhesin from staphylococcus epidermidis and method of use |
| 09/26/2002 | WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 09/26/2002 | WO2002074251A2 Monoclonal antibody therapy for pancreas cancer |
| 09/26/2002 | WO2002074244A2 Transcutaneous immunostimulation |
| 09/26/2002 | WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 09/26/2002 | WO2002074237A2 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 09/26/2002 | WO2002074193A2 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES |
| 09/26/2002 | WO2002074048A2 P-glycoproteins and uses thereof |
| 09/26/2002 | WO2002062999A8 Proteins and nucleic acids encoding same |
| 09/26/2002 | WO2002032945A3 Haemophilus influenzae basb206 gene and protein |
| 09/26/2002 | WO2002026996A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 09/26/2002 | WO2002024220A3 Vaccine comprising heat stress proteins from herbaceous plants |
| 09/26/2002 | WO2002022685A3 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002015918A3 Method and compositions for promoting osteogenesis |
| 09/26/2002 | WO2002009751A3 COMPOSITIONS FOR INDUCING SELF-SPECIFIC ANTI-IgE ANTIBODIES AND USES THEREOF |
| 09/26/2002 | WO2002000693A3 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001090143A3 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001023421A9 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 09/26/2002 | WO2001019861A9 Apo-2 receptor antibodies |
| 09/26/2002 | WO2001017554A9 Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins |
| 09/26/2002 | WO2000074634A9 Methods and compositions for modulating cell proliferation and cell death |
| 09/26/2002 | US20020138860 Novel uses of mammalian CCR6 receptors and related reagents |
| 09/26/2002 | US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 09/26/2002 | US20020137915 Conformational and topological protein regulation |
| 09/26/2002 | US20020137910 MN gene and protein |
| 09/26/2002 | US20020137899 Crosslinked through one or more carbohydrate moieties in said glycoprotein; storage stability, chemical stability over wider range of conditions while retaining bioactivity in use |
| 09/26/2002 | US20020137891 Inserting a nucleic acid sequence encoding a heterologous polypeptide into a nucleic acid sequence encoding subunit of an oligomerisable protein scaffold, incorporating it into expression vector to express nucleic acid to produce monomer |
| 09/26/2002 | US20020137761 Treating tolerance or drug addiction; analgesics |
| 09/26/2002 | US20020137720 Polynucleotide sequence; drug |
| 09/26/2002 | US20020137717 Use of chimeric mutational vectors to change endogenous nucleotide sequences in solid tissues |
| 09/26/2002 | US20020137716 Administering nucleotide sequence |
| 09/26/2002 | US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/26/2002 | US20020137683 For malignant melanoma and carcinoma of colon/rectum, ovaries, lungs, and prostates; epitopic; immunogens which elicit cytotoxic T lymphocyte responses |
| 09/26/2002 | US20020137681 Treatment of demyelinating autoimmune disease with ordered peptides |
| 09/26/2002 | US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137166 ASIP-related proteins |
| 09/26/2002 | US20020137165 As additives for human nutritive compositions or immunotherapeutics for cancer |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137111 Chlamydia heat shock protein |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020136776 Poly( alpha -hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136762 Lyophilized liposomes of at least two sizes are absorbed in the Peyer's patches of the gut of a mammal and are taken up by macrophages |
| 09/26/2002 | US20020136742 Outer membrane protein polypeptide lacking regions VD1 and VD2 |
| 09/26/2002 | US20020136741 Extracting with a polyoxyethylene detergent to deplete inner membranes, extracting remaining outer membranes with zwitterionic betaine dertergent to separate lipooligosaccharides from insoluble factions used for vaccines |